Kansas · 2025-2026 Regular Session · Bill

HB 2550: Requiring certain 340B entities to report annually to the Kansas department of insurance on certain costs, savings and payments made under the federal 340B drug pricing program.

Did not advance Last action April 10, 2026: Died in Committee

Plain-language summary

HB 2550 is a bill introduced in the Kansas House on January 27, 2026. According to its official title, it concerns: Requiring certain 340B entities to report annually to the Kansas department of insurance on certain costs, savings and payments made under the federal 340B drug pricing program. Primary sponsor: Committee on Insurance. Most recent recorded action (April 10, 2026): Died in Committee.

Sponsors

Primary sponsor: Committee on Insurance.